Moxifloxacin Acyl-b-D-glucuronide(733002-61-4)
- Name: Moxifloxacin Acyl-b-D-glucuronide
- Synonyms:1-[1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylate] b-D-Glucopyranuronic Aci;Moxifloxacin Acyl-b-D-glucuronide;1-[1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylate] -D-Glucopyranuronic Acid;Moxifloxacin Acyl--D-glucuronide
- Molecular Formula:C27H32 F N3 O10
- Molecular Weight:577.56
- CAS Registry Number:733002-61-4
- EINECS:
- Melting Point:170-173°C (dec.)
- Water Solubility:
CAS No.733002-61-4 Moxifloxacin Acyl-b-D-glucuronide
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.733002-61-4 Moxifloxacin Acyl-b-D-glucuronide
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:Moxifloxacin Acyl-b-D-glucuronide
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.733002-61-4 Moxifloxacin Acyl Glucuronide
Assay:95%+ or 98%+ Appearance:solid Package:10mg/25mg/50mg/100mg/1000mg/5000mg Storage:short-term storage normal temperature. long-term storage 2-8 鈩?nbsp;Application:for drug impurities, for drug standards,for drug research and development
Min. Order:0
Supplier:Hubei Moxin Biotechnology Co., Ltd [
China (Mainland)] CAS No.733002-61-4 Moxifloxacin acyl glucuronide
Assay:> 95% Appearance:Solid powder Application:For research use only.
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 733046-05-4/Oxiranecarboxamide, N,N,3,3-tetraethyl-2-methyl- (9CI)
- 75653-87-1/N-(3-AMINOPROPYL)-THIOMORPHOLINE
- 733045-96-0/Methanol, [(4-methylphenyl)imino]bis- (9CI)
- 733045-69-7/Benzamide, 4-[(aminoiminomethyl)amino]-N-2-oxazolyl- (9CI)
- 75653-86-0/3-(1H-PYRAZOL-1-YL)PROPAN-1-AMINE
- 733045-68-6/Benzamide, 4-[(aminoiminomethyl)amino]-N-4-pyridinyl- (9CI)
- 733045-66-4/Benzamide, 4-[(aminoiminomethyl)amino]-N-2-pyridinyl- (9CI)
- 733035-90-0/Furan, 2-(3,3-dimethyl-1-butynyl)- (9CI)
- 733034-56-5/7-[3-(4-FLUOROPHENYL)-1-(1-METHYLETHYL)-1H-INDOL-2-YL]-3,5-DIHYDROXY-4-(NITROOXY)BUTYL ESTER, 6-HEPTENOIC ACID
- 733034-46-3/1S,2S,6S,7,8S,8AR-HEXAHYDRO-BETA,DELTA,6-TRIHYDROXY-2-METHYL-8-[(2S)-2-METHYL-1-OXOBUTOXY]-4-(NITROOXY)BUTYL ESTER, 1-NAPHTHALENEHEPTANOIC ACID
- 75652-77-6/1H-Pyrrolizine-1,3(2H)-dione,tetrahydro-2-(1-hydroxyethylidene)-,[S-(Z)]-(9CI)
- 733019-48-2/Benzoic acid, 4-ethyl-, 2-amino-2-oxoethyl ester (9CI)
- 733019-13-1/1H-Pyrrole-2-carboxylicacid,1-(2-propynyl)-(9CI)
- 733015-18-4/Thieno[2,3-d]pyrimidin-4(1H)-one, 6-ethyl-2,3-dihydro-3-methyl-2-thioxo- (9CI)
- 733011-94-4/9-Oxabicyclo[3.3.1]nonane-2,6-diol, (1S,2R,5S,6R)- (9CI)
- 733011-73-9/9-Oxabicyclo[4.2.1]nonane-2,5-diol,monoacetate,(1S,2S,5R,6R)-(9CI)
- 733010-51-0/2H-Pyran-2-one,4-ethoxy-5,6-dihydro-6-phenyl-,(-)-(9CI)
- 733010-29-2/2H-Pyran-2-one,4-ethoxy-5,6-dihydro-6-phenyl-,(+)-(9CI)
- 733002-61-4/Moxifloxacin Acyl-b-D-glucuronide
- 75651-69-3/SUC-PHE-LEU-PHE-PNA
- 733000-93-6/2H-Pyran-2-one,tetrahydro-6-methyl-4-(1-methylethyl)-,(4S)-(9CI)
- 732995-64-1/5-Pyrimidinecarboxamide,N-(2-fluorophenyl)-1,2,3,4-tetrahydro-2,4-dioxo-
- 732992-32-4/Cyclopropanecarboxamide, 2-methyl-N-(2-methyl-4-oxo-3(4H)-quinazolinyl)-
- 732985-02-3/1,3-Cyclopentadiene,5-[(1S)-1,2,2-trimethylpropyl]-(9CI)
- 732984-10-0/1-Propen-1-ol, 1-ethoxy-2-methyl-
- 75651-68-2/SUC-PHE-PRO-PHE-PNA
- 732981-76-9/1H-Pyrazole-3,5-diamine,N3,N3-dimethyl-(9CI)
- 732980-67-5/5H-Thiazolo[3,2-a]pyrimidine,5-methyl-(9CI)
- 732979-10-1/3,4-Pyridinediamine,6-(1-methylethyl)-(9CI)
- 732978-23-3/Pentanoic acid, 2-amino-5-cyano-, methyl ester, (2S)- (9CI)